Abbott Laboratories (ABT)
118.60
+5.23
(+4.61%)
USD |
NYSE |
Nov 01, 16:00
119.14
+0.54
(+0.46%)
After-Hours: 20:00
Abbott Laboratories Debt to Equity Ratio: 0.3764 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.3764 |
| June 30, 2024 | 0.3752 |
| March 31, 2024 | 0.3758 |
| December 31, 2023 | 0.3803 |
| September 30, 2023 | 0.4143 |
| June 30, 2023 | 0.4532 |
| March 31, 2023 | 0.4566 |
| December 31, 2022 | 0.4572 |
| September 30, 2022 | 0.4601 |
| June 30, 2022 | 0.4593 |
| March 31, 2022 | 0.4828 |
| December 31, 2021 | 0.5042 |
| September 30, 2021 | 0.5345 |
| June 30, 2021 | 0.5474 |
| March 31, 2021 | 0.5496 |
| December 31, 2020 | 0.5718 |
| September 30, 2020 | 0.5914 |
| June 30, 2020 | 0.6436 |
| March 31, 2020 | 0.6047 |
| December 31, 2019 | 0.5835 |
| September 30, 2019 | 0.6002 |
| June 30, 2019 | 0.6058 |
| March 31, 2019 | 0.6161 |
| December 31, 2018 | 0.641 |
| September 30, 2018 | 0.7672 |
| Date | Value |
|---|---|
| June 30, 2018 | 0.676 |
| March 31, 2018 | 0.6972 |
| December 31, 2017 | 0.9038 |
| September 30, 2017 | 0.75 |
| June 30, 2017 | 0.7604 |
| March 31, 2017 | 0.7644 |
| December 31, 2016 | 1.072 |
| September 30, 2016 | 0.4096 |
| June 30, 2016 | 0.4311 |
| March 31, 2016 | 0.4145 |
| December 31, 2015 | 0.4244 |
| September 30, 2015 | 0.3958 |
| June 30, 2015 | 0.3808 |
| March 31, 2015 | 0.407 |
| December 31, 2014 | 0.3637 |
| September 30, 2014 | 0.3627 |
| June 30, 2014 | 0.312 |
| March 31, 2014 | 0.332 |
| December 31, 2013 | 0.2607 |
| September 30, 2013 | 0.3487 |
| June 30, 2013 | 0.3552 |
| March 31, 2013 | 0.3144 |
| December 31, 2012 | 0.7663 |
| September 30, 2012 | 0.6026 |
| June 30, 2012 | 0.7386 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.3752
Minimum
Jun 2024
0.6436
Maximum
Jun 2020
0.4911
Average
0.4715
Median
Debt to Equity Ratio Benchmarks
| Boston Scientific Corp | 0.5187 |
| Becton Dickinson & Co | 0.747 |
| ResMed Inc | 0.1304 |
| Integra Lifesciences Holdings Corp | 1.190 |
| QuidelOrtho Corp | 0.8078 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 74.36B |
| Total Liabilities (Quarterly) | 34.33B |
| Shareholders Equity (Quarterly) | 39.80B |
| Current Ratio | 1.597 |
| Net Debt Paydown Yield | 0.19% |